At-Home HPV test could help underserved women skip the clinic

NCT ID NCT03898167

Completed Prevention Sponsor: Baylor College of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether mailing HPV self-test kits to women who are overdue for cervical cancer screening could increase participation. Over 2,400 underserved women in Texas were randomly assigned to receive a kit or standard phone reminders. The goal was to see if the at-home option made it easier for women to get screened, especially those who face barriers to clinic visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mailed HPV self-sampling kit
What this could lead to: If successful, this approach could make cervical cancer screening more accessible for women who struggle to get to a clinic, potentially catching more cancers early.
What could go wrong: This is a completed study, but it only looked at whether women would use the kit and follow up. It does not prove that self-sampling reduces cancer deaths or works in all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer human papilloma virus infection Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER HUMAN PAPILLOMAVIRUS INFECTION

Contacts and locations

Locations

Harris Health System

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.